InvestorsHub Logo
Followers 1
Posts 348
Boards Moderated 0
Alias Born 03/05/2019

Re: weasel6667 post# 46141

Thursday, 09/19/2019 5:55:07 AM

Thursday, September 19, 2019 5:55:07 AM

Post# of 233768
I have not seen any company where this went smoothly and without delay. Some attack CYDY saying it's a scam. Yesterday, Yale University announced ten diseases that can be treated with CCR5 antagonists, every day someone writes about CCR5, they can't all be wrong. Leronlimab has been tested in over 830 patients without any serious side effects and has proven effective in blocking CCR5. Something that showed a high + 98% activity in mice, if it's half the value in humans, it's worth billions, and then if it works in most metastases where the CCR5 receptor occurs then this is a worldwide blockbuster. NP does not want to sell Leronlimab for 10% royalties and I support it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News